Terms: = Liver cancer AND GATA1, ERYF1, P15976, 2623, ENSG00000102145, NFE1, GF1 AND Treatment
6 results:
1. Clinically significant genomic alterations in the Chinese and Western patients with intrahepatic cholangiocarcinoma.
Xu S; Guo Y; Zeng Y; Song Z; Zhu X; Fan N; Zhang Z; Ren G; Zang Y; Rao W
BMC Cancer; 2021 Feb; 21(1):152. PubMed ID: 33579226
[TBL] [Abstract] [Full Text] [Related]
2. The thrombopoietin/MPL axis is activated in the gata1
Zingariello M; Sancillo L; Martelli F; Ciaffoni F; Marra M; Varricchio L; Rana RA; Zhao C; Crispino JD; Migliaccio AR
Blood Cancer J; 2017 Jun; 7(6):e572. PubMed ID: 28622305
[TBL] [Abstract] [Full Text] [Related]
3. Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma.
Kawamura Y; Arase Y; Ikeda K; Seko Y; Imai N; Hosaka T; Kobayashi M; Saitoh S; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Ohmoto Y; Amakawa K; Tsuji H; Kumada H
Am J Gastroenterol; 2012 Feb; 107(2):253-61. PubMed ID: 22008893
[TBL] [Abstract] [Full Text] [Related]
4. GATA-1 is essential in EGF-mediated induction of nucleotide excision repair activity and ERCC1 expression through ERK2 in human hepatoma cells.
Andrieux LO; Fautrel A; Bessard A; Guillouzo A; Baffet G; Langouët S
Cancer Res; 2007 Mar; 67(5):2114-23. PubMed ID: 17332341
[TBL] [Abstract] [Full Text] [Related]
5. WNT2 and human gastrointestinal cancer (review).
Katoh M
Int J Mol Med; 2003 Nov; 12(5):811-6. PubMed ID: 14533014
[TBL] [Abstract] [Full Text] [Related]
6. Human S mu binding protein-2 binds to the drug response element and transactivates the human apoA-I promoter: role of gemfibrozil.
Mohan WS; Chen ZQ; Zhang X; Khalili K; Honjo T; Deeley RG; Tam SP
J Lipid Res; 1998 Feb; 39(2):255-67. PubMed ID: 9507986
[TBL] [Abstract] [Full Text] [Related]